Hillevax

Hillevax Equity Growth

Delisted

The Year-over-Year Equity Growth of Hillevax (HLVX) as of Nov 20, 2026 is -41.82 %. In the previous year, Year-over-Year Equity Growth was -0.64 % — a change of 6,458.19% (lower).

Equity Growth

-41.82 %

YoY

6,458.19%

Last updated:

Year-over-Year Equity Growth of Hillevax is 2024 -41.82 % . Year-over-Year Equity Growth of Hillevax was 2023 -0.64 % . It decreases by 6,458.19% lower compared to the previous year.

The Hillevax Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2020
-313.26 USD
Jan 1, 2021
-3,533.50 USD
Jan 1, 2022
365.22 USD
Jan 1, 2023
-0.64 USD
Jan 1, 2024
-41.82 USD
The Hillevax Equity Growth history
YEAREquity GrowthYoY
-41.82 %+6,458.19%
-0.64 %-100.17%
365.22 %-110.34%
-3,533.50 %+1,027.96%
-313.26 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hillevax Stock analysis

What does Hillevax do? HilleVax, Inc. develops and commercializes novel vaccines, focusing on HIL-214, a bivalent virus-like particle (VLP) vaccine candidate for norovirus-induced acute gastroenteritis. The vaccine combines VLPs for norovirus genotypes GI.1 and GII.4 with an aluminum hydroxide adjuvant to enhance immune response. HIL-214 targets moderate-to-severe cases of norovirus infection, which causes symptoms like diarrhea, vomiting, and dehydration. The company's primary revenue stream will come from the future commercialization of HIL-214 after regulatory approval, with potential sales to healthcare providers and public health programs. Hillevax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hillevax stock

Year-over-Year Equity Growth of Hillevax is -41.82 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Hillevax since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Hillevax historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Hillevax

All Key Metrics — Hillevax